Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Alopecia areata in elderly people is usually mild and responds well to treatment.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Platelet-rich plasma injections can effectively treat alopecia areata barbae.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

A woman's hair loss led to discovering she had lupus.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.